Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

Michigan has confirmed its first measles case since last July. An Oakland County adult tested positive after recently ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...